Cancer Immunotherapy
Published on 14. May 2014
400 pages
978-0-08-046337-7 (ISBN)
Description
For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens. This thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research.
More details
Series
Language
English
Place of publication
San Diego
United States
Target group
Academic/professional/technical: Research and professional
Product notice
Windows
Illustrations
Illustrated
ISBN-13
978-0-08-046337-7 (9780080463377)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
James Allison | Glen Dranoff
Cancer Immunotherapy: Volume 90
Book
05/2006
Academic Press
€188.49
Shipment within 15-20 days
Content
Engineered cellular vaccinesBlockade of T cell checkpoints.Serex in the identification of target antigensNew approaches to tumor immunotherapyMelanoma antigensAntibodies and chimeric moleculesTumor ImmunosurveillanceDendritic CellsStrategies for Tumor VaccinationDNA vaccines
